U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H38N2O8
Molecular Weight 578.6527
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEFESERPINE

SMILES

CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=CC(OC)=CC=C45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)COC6=CC=C(OC)C=C6

InChI

InChIKey=KFDDPVMIQMFHBI-JLIPXIIDSA-N
InChI=1S/C32H38N2O8/c1-37-19-5-7-20(8-6-19)41-17-28(35)42-27-13-18-16-34-12-11-23-22-10-9-21(38-2)14-25(22)33-30(23)26(34)15-24(18)29(31(27)39-3)32(36)40-4/h5-10,14,18,24,26-27,29,31,33H,11-13,15-17H2,1-4H3/t18-,24+,26-,27-,29+,31+/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H38N2O8
Molecular Weight 578.6527
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Mefeserpine (Methoxyphenoserpine) is a hypotensive reserpoid with a weak central depressive effect.

CNS Activity

Curator's Comment: Mefeserpine (Methoxyphenoserpine) has a weak central depressive effect.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[THE USE OF METHOXYPHENOSERPINE, A RESERPINE DERIVATIVE, IN THE TREATMENT OF HYPERTENSIVE DISEASE].
1965-03
[CLINICAL EVALUATION OF METHOXYPHENOSERPINE, A SYNTHETIC DERIVATIVE OF RESERPINE].
1965
THE INFLUENCE OF A NEW RESERPINE DERIVATIVE, METHOXYPHENOSERPINE, ON EXPERIMENTAL ULCERS AND GASTRIC SECRETION IN RATS.
1964-05
[HYPOTENSIVE AND SIDE-EFFECTS OF METHOXYPHENOSERPINE, A NEW RESERPINE DERIVATIVE].
1963-11-15
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Humans: most common therapeutically effective dose is that of 7-12 mg. Decreasing of the blood pressure appears after 3 or sometimes even 6 weeks since the beginning of the treatment. https://www.ncbi.nlm.nih.gov/pubmed/14332286
Rats: The dose of 25.0 mg/kg causing the comparable increase of the concentration of pepsin in the gastric juice of normal rats is 5 times higher than that of reserpine.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:36:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:36:18 GMT 2025
Record UNII
42EL4L295A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MEFESERPINE
INN  
INN  
Official Name English
METHYL RESERPATE ESTER OF (P-METHOXYPHENOXY)ACETIC ACID
Preferred Name English
mefeserpine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C270
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
Code System Code Type Description
PUBCHEM
3045407
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105820
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
EVMPD
SUB08707MIG
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
CAS
3735-85-1
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
SMS_ID
100000081440
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
NCI_THESAURUS
C87628
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
FDA UNII
42EL4L295A
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID0046721
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
INN
1792
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY